The optimization of recombinant antibody production from Chinese hamster ovary (CHO) cells is a paramount challenge with the biopharmaceutical industry. Various strategies are employed enhance antibody titer, comprising process parameter optimization, cell line development, and the use of perfusion processes. Fine-tuning culture conditions plays